Obesity Trials in Aurora, United States
Conditions / Obesity / Aurora, United States
Obesity is a medical condition with active clinical research programs worldwide.
103 total trials for this combination
Showing top 10 of 103 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05929066 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03620773 | Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes | COMPLETED | PHASE1/PHASE2 |
| NCT05556512 | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00807768 | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer | UNKNOWN | PHASE3 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT04300478 | Appetite and Exercise in Breast Cancer Survivors | COMPLETED | NA |
| NCT04992299 | Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents | COMPLETED | NA |
| NCT03574597 | Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity | COMPLETED | PHASE3 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT01112839 | Reducing Breast Cancer Recurrence With Weight Loss | COMPLETED | NA |